Alyeska Investment Group’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-209,866
| Closed | -$18.1M | – | 615 |
|
|
2024
Q4 | $18.1M | Sell |
209,866
-608,019
| -74% | -$52.3M | 0.07% | 268 |
|
|
2024
Q3 | $97.4M | Buy |
817,885
+560,893
| +218% | +$66.8M | 0.5% | 54 |
|
|
2024
Q2 | $36.7M | Buy |
+256,992
| New | +$36.7M | 0.21% | 137 |
|
|
2023
Q1 | – | Sell |
-388,090
| Closed | -$52.5M | – | 499 |
|
|
2022
Q4 | $52.5M | Sell |
388,090
-79,719
| -17% | -$10.8M | 0.54% | 59 |
|
|
2022
Q3 | $46.6M | Sell |
467,809
-516,144
| -52% | -$51.4M | 0.54% | 59 |
|
|
2022
Q2 | $110M | Buy |
983,953
+83,497
| +9% | +$9.3M | 1.25% | 9 |
|
|
2022
Q1 | $100M | Buy |
900,456
+434,841
| +93% | +$48.3M | 1.1% | 9 |
|
|
2021
Q4 | $52.1M | Buy |
465,615
+1,591
| +0.3% | +$178K | 0.6% | 52 |
|
|
2021
Q3 | $44.6M | Buy |
464,024
+280,965
| +153% | +$27M | 0.55% | 46 |
|
|
2021
Q2 | $15.3M | Sell |
183,059
-241,941
| -57% | -$20.3M | 0.18% | 160 |
|
|
2021
Q1 | $28.7M | Buy |
+425,000
| New | +$28.7M | 0.37% | 75 |
|
|
2020
Q1 | – | Sell |
-1,074,555
| Closed | -$62.2M | – | 415 |
|
|
2019
Q4 | $62.2M | Sell |
1,074,555
-101,220
| -9% | -$5.86M | 0.82% | 30 |
|
|
2019
Q3 | $60.8M | Buy |
1,175,775
+742,914
| +172% | +$38.4M | 0.88% | 26 |
|
|
2019
Q2 | $22.1M | Buy |
432,861
+132,861
| +44% | +$6.78M | 0.29% | 114 |
|
|
2019
Q1 | $15.7M | Buy |
+300,000
| New | +$15.7M | 0.21% | 130 |
|